Leads Biolabs

Nanjing Leadsbiolabs Co., Ltd. was founded in 2012 as a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of innovative therapies to address unmet medical needs in oncology, autoimmune diseases, and other major diseases in China and globally. As a leader in next-generation cancer immunotherapy, we possess a differentiated pipeline of 12 innovative drug candidates, six of which have successfully entered clinical stages, with four key products among the leading global clinical candidates.